Netta Jagpal

2024

In 2024, Netta Jagpal earned a total compensation of $120.5K as Chief Financial Officer at InMed Pharmaceuticals.

Compensation breakdown

Bonus$19,100
Option Awards$13,800
Salary$87,600
Total$120,500

Jagpal received $87.6K in salary, accounting for 73% of the total pay in 2024.

Jagpal also received $19.1K in bonus and $13.8K in option awards.

Rankings

In 2024, Netta Jagpal's compensation ranked 145th out of 152 executives tracked by ExecPay. In other words, Jagpal earned more than 4.6% of executives.

ClassificationRankingPercentile
All
145
out of 152
5th
Division
Manufacturing
63
out of 66
5th
Major group
Chemicals And Allied Products
25
out of 26
4th
Industry group
Drugs
25
out of 26
4th
Industry
Pharmaceutical Preparations
22
out of 23
4th
Source: SEC filing on October 28, 2024.

Jagpal's colleagues

We found five more compensation records of executives working with Netta Jagpal at InMed Pharmaceuticals in 2024.

2024

Eric Adams

InMed Pharmaceuticals

Chief Executive Officer

2024

Michael Woudenberg

InMed Pharmaceuticals

Chief Operating Officer

2024

Eric Hsu

InMed Pharmaceuticals

Senior Vice President, Preclinical Research & Development

2024

Alexandra Mancini

InMed Pharmaceuticals

Senior Vice President, Clinical & Regulatory Affairs

2024

Jonathan Tegge

InMed Pharmaceuticals

Chief Financial Officer

News

You may also like